Marion G. Peters mostly deals with Internal medicine, Immunology, Gastroenterology, Hepatitis B and Hepatitis B virus. Marion G. Peters has researched Internal medicine in several fields, including Surgery and Placebo-controlled study. Her study in Gastroenterology is interdisciplinary in nature, drawing from both Biopsy, Liver biopsy, Randomized controlled trial and Alpha interferon.
Her Hepatitis B research is multidisciplinary, incorporating perspectives in Position paper, Malaria, Global health, Public health and Tuberculosis. Her Hepatitis B virus research is within the category of Virology. As a part of the same scientific family, Marion G. Peters mostly works in the field of Hepatitis, focusing on Interferon type I and, on occasion, Immunotherapy.
Immunology, Internal medicine, Virology, Gastroenterology and Hepatitis C are her primary areas of study. In her study, Chronic liver disease is inextricably linked to Liver disease, which falls within the broad field of Immunology. Her Internal medicine research integrates issues from Coinfection and Acquired immunodeficiency syndrome.
Her work investigates the relationship between Virology and topics such as Immune system that intersect with problems in Disease. Her work carried out in the field of Gastroenterology brings together such families of science as Fibrosis, Surgery and Alpha interferon. The Hepatitis C study combines topics in areas such as Prospective cohort study, Cohort study, Viral load and Cohort.
The scientist’s investigation covers issues in Internal medicine, Hepatitis C virus, Gastroenterology, Immunology and Hepatitis B virus. In her research on the topic of Internal medicine, Cirrhosis and Viral load is strongly related with Coinfection. To a larger extent, Marion G. Peters studies Virology with the aim of understanding Hepatitis C virus.
The concepts of her Gastroenterology study are interwoven with issues in Interquartile range and Fatty liver. Her work in Immunology addresses issues such as Genotype, which are connected to fields such as Odds ratio. Her research in Hepatitis B virus intersects with topics in Viral hepatitis, Hepatitis B and Hepatocellular carcinoma.
Her scientific interests lie mostly in Internal medicine, Hepatitis C virus, Hepatitis B virus, Virology and Coinfection. Her Internal medicine study frequently draws connections between related disciplines such as Gastroenterology. Her studies in Gastroenterology integrate themes in fields like Surgery, Adverse effect and Alpha interferon.
Her Hepatitis C virus research is classified as research in Immunology. Her research investigates the connection with Hepatitis B virus and areas like Hepatitis B which intersect with concerns in Intensive care medicine and Global health. Marion G. Peters interconnects Interquartile range and Cohort in the investigation of issues within Hepatitis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.
Hoofnagle Jh;Mullen Kd;Jones Db;Rustgi.
The New England Journal of Medicine (1986)
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.
Raymond T. Chung;Janet Andersen;Paul Volberding;Gregory K. Robbins.
The New England Journal of Medicine (2004)
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.
Marion G. Peters;H. W. Hann;Paul Martin;E. Jenny Heathcote.
Gastroenterology (2004)
Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B
Jay H. Hoofnagle;Jay H. Hoofnagle;Marion Peters;Marion Peters;Kevin D. Mullen;Kevin D. Mullen;D.Brian Jones;D.Brian Jones.
Gastroenterology (1988)
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.
Francis Y. Yao;Robert K. Kerlan;Ryutaro Hirose;Timothy J. Davern.
Hepatology (2008)
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
Raymond T. Chung;Marc G. Ghany;Arthur Y. Kim;Kristen M. Marks.
Clinical Infectious Diseases (2018)
Psychiatric complications of long-term interferon alfa therapy.
Pierre F. Renault;Jay H. Hoofnagle;Yoon Park;Kevin D. Mullen.
JAMA Internal Medicine (1987)
Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.
Vincent Soriano;Massimo Puoti;Mark Sulkowski;Antonietta Cargnel.
AIDS (2007)
Hepatitis B virus infection
Man-Fung Yuen;Ding-Shinn Chen;Ding-Shinn Chen;Geoffrey M. Dusheiko;Harry L. A. Janssen.
Nature Reviews Disease Primers (2018)
Viral Hepatitis in HIV Infection
Margaret James Koziel;Marion G. Peters.
The New England Journal of Medicine (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of California, San Francisco
Harvard University
National Institutes of Health
University of Cincinnati Medical Center
Harvard Medical School
Johns Hopkins University
University College London
Georgetown University
Albert Einstein College of Medicine
Harvard University
University of Arizona
Durham University
Technical University of Berlin
Tsinghua University
University of Leeds
National University of Singapore
Queen Mary University of London
University of North Carolina at Chapel Hill
Sapienza University of Rome
Radboud University Nijmegen
Boston Children's Hospital
Philipp University of Marburg
University of Leicester
University Medical Center Utrecht